Michael Rodriguez
- Reproductive Medicine top 1%
- Obstetrics and Gynecology top 1%
- Epidemiology top 5%
- Surgery top 10%
- Oncology top 10%
- Co-authors
- Peter G. RoseFadi W. Abdul‐KarimNancy FuscoFloro MiraldiLee P. AdlerPeter FaulhaberMegan SteainAllison Abendroth
- Topics
- Ovarian cancer diagnosis and treatment (16 papers)Endometrial and Cervical Cancer Treatments (9 papers)Intraperitoneal and Appendiceal Malignancies (9 papers)
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
Michael Rodriguez
85 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 130
- Reproductive Medicine 668
- Obstetrics and Gynecology 580
- Epidemiology 499
- Surgery 485
- Oncology 401
Countries citing papers authored by Michael Rodriguez
This map shows the geographic impact of Michael Rodriguez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Rodriguez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Rodriguez more than expected).
Fields of papers citing papers by Michael Rodriguez
This network shows the impact of papers produced by Michael Rodriguez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Rodriguez. The network helps show where Michael Rodriguez may publish in the future.
Co-authorship network of co-authors of Michael Rodriguez
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Rodriguez. A scholar is included among the top collaborators of Michael Rodriguez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Rodriguez. Michael Rodriguez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 5 | |
| 5 | 81 | |
| 6 | 97 | |
| 7 | 60 | |
| 8 | 1 | |
| 9 | 22 | |
| 10 | 14 | |
| 11 | 5 | |
| 12 | 9 | |
| 13 | 27 | |
| 14 | 40 | |
| 15 | Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci. | 18 |
| 16 | 13 | |
| 17 | 45 | |
| 18 | 9 | |
| 19 | 59 | |
| 20 | 12 |
About Michael Rodriguez
Michael Rodriguez is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Otorhinolaryngology, having authored 90 papers that have together received 2.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (16 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Intraperitoneal and Appendiceal Malignancies (9 papers). The work is most often cited by research in Reproductive Medicine (668 citations), Obstetrics and Gynecology (580 citations) and Otorhinolaryngology (90 citations). Michael Rodriguez has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Peter G. Rose, Fadi W. Abdul‐Karim, Nancy Fusco, Floro Miraldi, Lee P. Adler, Peter Faulhaber, Megan Steain, Allison Abendroth, Barry Slobedman and Patricia Rose. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.